Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,183,643 papers from all fields of science
Search
Sign In
Create Free Account
Mepenzolate bromide
Known as:
N-methyl-3-piperidylbenzilate methyl bromide
, mepenzolic acid, bromine salt
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (2)
Benzilates
Piperidines
Narrower (1)
Cantil
Mepenzolate
Mepenzolate 25 MG Oral Tablet [Cantil]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity.
Yasunobu Yamashita
,
Ken-ichiro Tanaka
,
+7 authors
T. Mizushima
Bioorganic & medicinal chemistry
2019
Corpus ID: 189943561
2018
2018
Identification of Mepenzolate Derivatives With Long-Acting Bronchodilatory Activity
Ken-ichiro Tanaka
,
N. Yamakawa
,
+7 authors
T. Mizushima
Front. Pharmacol.
2018
Corpus ID: 4714177
The standard treatment for chronic obstructive pulmonary disease is a combination of anti-inflammatory drugs and bronchodilators…
Expand
Highly Cited
2017
Highly Cited
2017
Effect of Niacin on Inflammation and Angiogenesis in a Murine Model of Ulcerative Colitis
H. Salem
,
W. Wadie
Scientific Reports
2017
Corpus ID: 415026
Butyrate and niacin are produced by gut microbiota, however butyrate has received most attention for its effects on colonic…
Expand
2016
2016
Mepenzolate bromide promotes diabetic wound healing by modulating inflammation and oxidative stress.
YongJun Zheng
,
Xingtong Wang
,
+8 authors
Z. Xia
American journal of translational research
2016
Corpus ID: 22583385
Diabetic wounds are characterized by persistent inflammation and the excessive production of reactive oxygen species, thus…
Expand
2014
2014
Superiority of pulmonary administration of mepenzolate bromide over other routes as treatment for chronic obstructive pulmonary disease
Ken-ichiro Tanaka
,
Shota Kurotsu
,
+9 authors
T. Mizushima
Scientific reports
2014
Corpus ID: 17163073
We recently proposed that mepenzolate bromide (mepenzolate) would be therapeutically effective against chronic obstructive…
Expand
2014
2014
Ameliorative Effect of Mepenzolate Bromide against Pulmonary Fibrosis
Shota Kurotsu
,
Ken-ichiro Tanaka
,
+5 authors
T. Mizushima
The Journal of Pharmacology and Experimental…
2014
Corpus ID: 777124
Idiopathic pulmonary fibrosis is thought to involve lung injury caused by reactive oxygen species (ROS), which in turn is…
Expand
2013
2013
Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease.
Ken-ichiro Tanaka
,
T. Ishihara
,
+10 authors
T. Mizushima
Nature communications
2013
Corpus ID: 5451226
The clinical treatment of chronic obstructive pulmonary disease (COPD) requires not only an improvement of airflow by…
Expand
1983
1983
Failure to demonstrate effectiveness of an anticholinergic drug in the symptomatic treatment of acute travelers' diarrhea.
R. Reves
,
P. Bass
,
H. Dupont
,
P. Sullivan
,
J. Mendiola
Journal of clinical gastroenterology
1983
Corpus ID: 9599464
Seventy adults in the United States with acute diarrhea who were attending classes in Guadalajara, Mexico, enrolled in a double…
Expand
1979
1979
Mianserin and agranulocytosis.
D. Curson
,
A. Hale
British medical journal
1979
Corpus ID: 17606483
An alcoholic woman who was admitted to hospital for detoxification was prescribed thyroxine because of hypothyroidism and…
Expand
1972
1972
Oral absorption of 14 C-labeled mepenzolate bromide in humans.
H. L. Friedman
,
R. Wang
Journal of pharmaceutical sciences
1972
Corpus ID: 32837396
In a pilot study, a single oral dose of 25 or 30 mg. of mepenzolate bromide containing approximately 24μc. of 14C was given to…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE